Company intelligence / Profile preview

MOD

Boonton, New Jersey, United Statesmod.io ↗

Ownership: Private
Development stage: Commercial

Overview

MOD3 Pharma is an integrated CDMO specializing in innovative oral inhalation and nasal drug product delivery. The company enables new oral treatment opportunities for drugs typically delivered by injection. It has advanced multiple projects into the clinic on behalf of clients and through its own development efforts. Its state-of-the-art GMP facility includes high-potency API containment.

Modalities: Small moleculeBiologicOral drug delivery technologies (OINDP)
Industry: Contract Manufacturing Organization

Partnerships

Partners with pharmaceutical companies as clients.

Beyond the preview

Go deeper on MOD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MOD.

Explore the full profile